Atezolizumab,Bevacizumab
Roche
['hcc', 'arca, (-arcade)']
very proud of for challenging the dogma of systemic and in particular immunotherapy in cp-b liver dysfunction. much needed data to broaden the reach of systemic therapy in patients with #hcc #wcgic2023 
Medical Oncologist, MD PhD, Director of Developmental Therapeutics @ImperialCollege ❤️ HCC, Immunotherapy and drug development. 🇮🇹 🇬🇧 🏳️‍🌈